Global Vaccine Market Forecast to Surpass $50 Billion by 2024

Global Vaccine Market Forecast to Surpass $50 Billion by 2024

The global vaccine market is forecast to reach $50.9 billion by 2024, according to a new study released by Market Study Report of Selbyville, Delaware. This projection would represent an increase of 30.45 percent over today’s vaccines market, estimated at $35.4 billion, or a compound annual growth rate of about 6.2 percent.1 2 The revenue […]

Popular DNA Testing Company Signs $300 Million Deal With Big Pharmaceutical Company

Popular DNA Testing Company Signs $300 Million Deal With Big Pharmaceutical Company

It might be time for people to reconsider before they spit in a tube. Online genetic testing services are wildly popular. Many people use services such as 23andMe and Ancestry.com to learn about their ancestral pasts. Many also use these services to gain more profound insights into their biological makeup, which is often used to […]

Global Vaccine Market Projected to Surge to $58 Billion by 2025

Global Vaccine Market Projected to Surge to $58 Billion by 2025

The global vaccine market is expected to surge to $57.5 billion by 2025, up from $33.7 billion in 2018, according to new figures from market research firm Research and Markets of Dublin, Ireland. The 7.9 percent compound annual growth rate (CAGR) predicted for the next 20 years is attributed to “increasing government initiatives towards immunization,” […]

FDA Official Uses Revolving Door to Join BioTech Company Developing mRNA Vaccines

FDA Official Uses Revolving Door to Join BioTech Company Developing mRNA Vaccines

U.S. Food and Drug Administration (FDA) official Wellington Sun, MD has been hired by biotechnology company Moderna Therapeutics, Inc. of Cambridge, MA to head its Vaccine Strategy and Regulatory Affairs division. Dr. Sun was director of the Division of Vaccines and Related Product Applications at the FDA’s Center for Biologics Evaluation and Research (CBER) where he […]

Drug Companies Pay FDA and NIH to Fast Track and Market Vaccines

Drug Companies Pay FDA and NIH to Fast Track and Market Vaccines

When it comes to cozy business relationships between government and industry, there is nothing like the lucrative one that Congress has encouraged federal health agencies to create with the drug and vaccine industry. One hand washes the other. Have you ever wondered how some new drugs and vaccines vault to the front of the line […]

Global Vaccines Market Worth $48 Billion by 2025

Global Vaccines Market Worth $48 Billion by 2025

The global vaccines market is projected to reach $48 billion by 2025, according to new estimates detailed in a report from Transparency Market Research. The anticipated cumulative annual growth rate (CAGR) of six percent from 2017 to 2025, however, is lower than the research firm’s previous estimate. In 2016, Transparency Market…

DPT Vaccines Recalled in China

DPT Vaccines Recalled in China

The China Food and Drug Administration (CFDA) announced on November 6, 2017 that batches of the Diphtheria, Pertussis and Tetanus (DPT) vaccine from two companies, Changchun Changsheng BioTech and Wuhan Institute of Biological Products, did not meet national standards

Therapeutic Vaccine Market is Big Business

Therapeutic Vaccine Market is Big Business

When the U.S. Food and Drug Administration (FDA) approved the first “therapeutic vaccine,” which is defined as a therapy that manipulates the immune system, a whole new market opened up for the vaccine industry. Driven as it is by an increasing worldwide incidence of…

Pharma Won’t Fund Heroin Vaccine Trials

Pharma Won’t Fund Heroin Vaccine Trials

In the wake of the widely reported opioid addiction crisis in the United States, there has been a significant amount of speculation and discussion in the media about drug addiction vaccines, particularly for heroin. The Vaccine Reaction has been tracking this issue for several years.

Clinical Study Explores mRNA-Based Technology for Vaccines

Clinical Study Explores mRNA-Based Technology for Vaccines

On July 25, 2017, the British journal The Lancet published results of an early-stage trial that could herald the arrival of a whole new class of vaccines. CureVac, a German biopharmaceutical company that focuses on therapeutic applications using messenger RNA (mRNA), announced “proof of concept” results from their Phase I study…

1 2 3